PURPOSE: This study was undertaken to describe cancer risk assessment practices among primary care providers (PCPs). METHODS: An electronic survey was sent to PCPs affiliated with a single insurance carrier. Demographic and practice characteristics associated with cancer genetic risk assessment and testing activities were described. Latent class analysis supported by likelihood ratio tests was used to define PCP profiles with respect to the level of engagement in genetic risk assessment and referral activity based on demographic and practice characteristics. RESULTS: 860 physicians responded to the survey (39% family practice, 29% internal medicine, 22% obstetrics/gynecology (OB/GYN), 10% other). Most respondents (83%) reported that they routinely assess hereditary cancer risk; however, only 33% reported that they take a full, three-generation pedigree for risk assessment. OB/GYN specialty, female gender, and physician access to a genetic counselor were independent predictors of referral to cancer genetics specialists. Three profiles of PCPs, based upon referral practice and extent of involvement in genetics evaluation, were defined. CONCLUSION: Profiles of physician characteristics associated with varying levels of engagement with cancer genetic risk assessment and testing can be identified. These profiles may ultimately be useful in targeting decision support tools and services.
PURPOSE: This study was undertaken to describe cancer risk assessment practices among primary care providers (PCPs). METHODS: An electronic survey was sent to PCPs affiliated with a single insurance carrier. Demographic and practice characteristics associated with cancer genetic risk assessment and testing activities were described. Latent class analysis supported by likelihood ratio tests was used to define PCP profiles with respect to the level of engagement in genetic risk assessment and referral activity based on demographic and practice characteristics. RESULTS: 860 physicians responded to the survey (39% family practice, 29% internal medicine, 22% obstetrics/gynecology (OB/GYN), 10% other). Most respondents (83%) reported that they routinely assess hereditary cancer risk; however, only 33% reported that they take a full, three-generation pedigree for risk assessment. OB/GYN specialty, female gender, and physician access to a genetic counselor were independent predictors of referral to cancer genetics specialists. Three profiles of PCPs, based upon referral practice and extent of involvement in genetics evaluation, were defined. CONCLUSION: Profiles of physician characteristics associated with varying levels of engagement with cancer genetic risk assessment and testing can be identified. These profiles may ultimately be useful in targeting decision support tools and services.
Authors: Beth A Reboussin; Eun-Young Song; Anshu Shrestha; Kurt K Lohman; Mark Wolfson Journal: Drug Alcohol Depend Date: 2005-12-15 Impact factor: 4.492
Authors: Susan E Collins; Iris Torchalla; Martina Schröter; Gerhard Buchkremer; Anil Batra Journal: Int J Methods Psychiatr Res Date: 2008-06 Impact factor: 4.035
Authors: Wylie Burke; Louise Acheson; Jeffery Botkin; Kenneth Bridges; Ardis Davis; James Evans; Jaime Frias; James Hanson; Norman Kahn; Ruth Kahn; David Lanier; Linda E Pinsky; Nancy Press; Michele A Lloyd-Puryear; Eugene Rich; Nancy Stevens; Elizabeth Thomson; Steven Wartman; Modena Wilson Journal: Community Genet Date: 2002
Authors: Nan M Solomons; Amanda E Lamb; Frances L Lucas; Eileen F McDonald; Susan Miesfeldt Journal: Telemed J E Health Date: 2017-07-21 Impact factor: 3.536
Authors: Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters Journal: Contemp Clin Trials Date: 2018-09-18 Impact factor: 2.226
Authors: Anita Y Kinney; Laurie E Steffen; Barbara H Brumbach; Wendy Kohlmann; Ruofei Du; Ji-Hyun Lee; Amanda Gammon; Karin Butler; Saundra S Buys; Antoinette M Stroup; Rebecca A Campo; Kristina G Flores; Jeanne S Mandelblatt; Marc D Schwartz Journal: J Clin Oncol Date: 2016-06-20 Impact factor: 44.544
Authors: Tuya Pal; Deborah Cragun; Courtney Lewis; Andrea Doty; Maria Rodriguez; Cristi Radford; Zachary Thompson; Jongphil Kim; Susan T Vadaparampil Journal: Genet Test Mol Biomarkers Date: 2013-02-28